U.K., Germany, Hungary Disassociate From Resolution On Drug Pricing Transparency Passed By World Health Assembly

The Guardian: U.K. refuses to back ‘game-changing’ resolution on drug pricing
“The U.K. government has refused to sign up to a global resolution on greater transparency for drug pricing. The resolution urges governments and others buying health products to share information on actual prices paid, and pushes for greater transparency on patents, clinical trial results, and other factors affecting pricing from laboratories to patients. … [T]he U.K., Germany, and Hungary have disassociated themselves from the resolution, which had already been watered down…” (Lamble, 5/28).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.